Neogen (NASDAQ:NEOG) Stock Rating Lowered by Wall Street Zen

Neogen (NASDAQ:NEOG) was downgraded by research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued to investors on Saturday.

NEOG has been the subject of several other reports. CJS Securities raised Neogen from a “market perform” rating to an “outperform” rating and set a $10.00 price target for the company in a report on Wednesday, December 10th. Piper Sandler set a $6.50 target price on Neogen and gave the company a “neutral” rating in a report on Thursday, October 16th. Guggenheim restated a “buy” rating and set a $12.00 target price (up from $8.00) on shares of Neogen in a research report on Friday. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Neogen in a report on Monday, December 29th. Two research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $9.50.

Neogen Stock Down 0.9%

Shares of NASDAQ:NEOG opened at $9.62 on Friday. Neogen has a fifty-two week low of $3.87 and a fifty-two week high of $12.98. The company has a quick ratio of 2.80, a current ratio of 3.91 and a debt-to-equity ratio of 0.38. The firm’s 50-day simple moving average is $6.66 and its 200-day simple moving average is $5.90. The company has a market cap of $2.09 billion, a price-to-earnings ratio of -3.47 and a beta of 1.96.

Neogen (NASDAQ:NEOG) last announced its quarterly earnings data on Thursday, January 8th. The company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of $0.07 by $0.03. Neogen had a negative net margin of 68.47% and a positive return on equity of 2.14%. The firm had revenue of $224.69 million during the quarter, compared to the consensus estimate of $208.50 million. During the same quarter last year, the firm earned $0.11 earnings per share. The firm’s revenue was down 2.9% compared to the same quarter last year. As a group, equities research analysts predict that Neogen will post 0.38 earnings per share for the current year.

Institutional Investors Weigh In On Neogen

Several institutional investors and hedge funds have recently made changes to their positions in the business. California State Teachers Retirement System grew its stake in Neogen by 1.1% in the 2nd quarter. California State Teachers Retirement System now owns 191,084 shares of the company’s stock valued at $913,000 after acquiring an additional 2,166 shares during the last quarter. Avanza Fonder AB grew its position in shares of Neogen by 17.9% in the second quarter. Avanza Fonder AB now owns 16,435 shares of the company’s stock valued at $79,000 after purchasing an additional 2,499 shares during the last quarter. Sage Rhino Capital LLC grew its position in shares of Neogen by 25.2% in the third quarter. Sage Rhino Capital LLC now owns 16,618 shares of the company’s stock valued at $95,000 after purchasing an additional 3,343 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its stake in shares of Neogen by 7.3% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 50,707 shares of the company’s stock worth $242,000 after purchasing an additional 3,463 shares in the last quarter. Finally, Mercer Global Advisors Inc. ADV raised its position in shares of Neogen by 27.8% during the 3rd quarter. Mercer Global Advisors Inc. ADV now owns 16,199 shares of the company’s stock worth $92,000 after purchasing an additional 3,522 shares during the last quarter. 96.73% of the stock is currently owned by hedge funds and other institutional investors.

Trending Headlines about Neogen

Here are the key news stories impacting Neogen this week:

• Positive Sentiment: Q2 results beat consensus on key metrics and management raised FY2026 revenue guidance to $845–$855M (above consensus), signaling progress on a turnaround; investors liked the combination of revenue outperformance and guidance lift. Neogen Raises Guidance as Cost-Cutting Takes Hold
• Positive Sentiment: Market reaction: the stock spiked sharply (reports note moves >30%) after the earnings and guidance, reflecting renewed investor optimism about revenue growth and cost actions. Why Neogen Stock Blasted More Than 31% Higher Today
• Positive Sentiment: Heavy bullish options activity and call buying accompanied the move (unusually large call volume), suggesting speculative and institutional interest in the near-term upside. Neogen Posts Strong Q2 Earnings
• Neutral Sentiment: Analyst & institutional context: a small number of upgrades and divergent price targets mean consensus is still forming; some funds have been reallocating positions into/out of NEOG. Q2 2026 Earnings Call Transcript
• Negative Sentiment: Underlying GAAP metrics remain mixed: some reports show the company recorded operating and net losses and weaker operating cash flow in the quarter (contrast between adjusted EPS and GAAP results creates ambiguity about sustainable profitability). That tempers the bullish narrative and raises execution risk. QuiverQuant Q2 Earnings Summary

Neogen Company Profile

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.